Clarithromycin - 96.0-102.0% (HPLC), high purity , CAS No.81103-11-9

8 Citations
Item Number
C434244
Grouped product items
SKUSizeAvailabilityPrice Qty
C434244-100mg
100mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$58.90

Basic Description

Synonyms6-O-methyl erythromycin | CLARITHROMYCIN (USP IMPURITY) | CLARITHROMYCIN [INN] | DTXCID40820062 | 8-Hydroxy-3,4-dihydrocarbstyril | CAS-81103-11-9 | Clacee | Bicrolid | Boc-Leu-OH.H2O | CLARITHROMYCIN (USP-RS) | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S
Specifications & PurityMoligand™, ≥96%(HPLC)
Biochemical and Physiological MechanismsClarithromycin possess bactericidal activity including anti-mycobacterial activity against Mycobacterium leprae , and M.avium complex. Clarithromycin is stable in gastric acid. Clarithromycin is a macrolide antibiotic that interferes with bacterial
Storage TempStore at 2-8°C
Shipped InWet ice
GradeMoligand™
Product Description

Application

Clarithromycin has been used to study its effect on the potassium channel KCNJ5 WT .


Other Notes

Keep container tightly closed in a dry and well-ventilated place. Keep in a dry place.

Associated Targets(Human)

CTH Tchem Cystathionine gamma-lyase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP1A2 Tchem Cytochrome P450 1A2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD2 Tclin D(2) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD4 Tchem D(4) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CYP3A4 Tclin Cytochrome P450 3A4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ELANE Tclin Neutrophil elastase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EGFR Tclin Epidermal growth factor receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AVPR1A Tclin Vasopressin V1a receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HDAC6 Tclin Histone deacetylase 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HRH1 Tclin Histamine H1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLCO1B3 Tchem Solute carrier organic anion transporter family member 1B3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A3 Tclin Sodium-dependent dopamine transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SLC6A4 Tclin Sodium-dependent serotonin transporter (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PTGS1 Tclin Prostaglandin G/H synthase 1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CA2 Tclin Carbonic anhydrase 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
DRD3 Tclin D(3) dopamine receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM3 Tclin Muscarinic acetylcholine receptor M3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2B Tclin Alpha-2B adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA2C Tclin Alpha-2C adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2A Tclin 5-hydroxytryptamine receptor 2A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA2A Tclin Adenosine receptor A2a (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ACHE Tclin Acetylcholinesterase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1B Tclin Alpha-1B adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADRA1A Tclin Alpha-1A adrenergic receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AR Tclin Androgen receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
MAOA Tclin Amine oxidase [flavin-containing] A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
AKR1B1 Tclin Aldose reductase (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA1 Tclin Adenosine receptor A1 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR1A Tclin 5-hydroxytryptamine receptor 1A (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
ADORA3 Tchem Adenosine receptor A3 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR6 Tchem 5-hydroxytryptamine receptor 6 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
HTR2B Tclin 5-hydroxytryptamine receptor 2B (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
F2 Tclin Prothrombin (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
EDNRA Tclin Endothelin-1 receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRD1 Tclin Delta-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRK1 Tclin Kappa-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
OPRM1 Tclin Mu-type opioid receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NOS2 Tchem Nitric oxide synthase, inducible (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
TACR1 Tclin Substance-P receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
NOS1 Tchem Nitric oxide synthase, brain (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
PDE5A Tclin Phosphodiesterase 5A (5113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
F2 Tclin Thrombin (11687 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR1 Tclin Estrogen receptor alpha (17718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMGCR Tclin HMG-CoA reductase (2475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
INSR Tclin Insulin receptor (5558 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PGR Tclin Progesterone receptor (8562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB2 Tclin Beta-2 adrenergic receptor (11824 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM2 Tclin Muscarinic acetylcholine receptor M2 (10671 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRB1 Tclin Beta-1 adrenergic receptor (6630 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AR Tclin Androgen Receptor (11781 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM1 Tclin Muscarinic acetylcholine receptor M1 (12690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD4 Tchem Dopamine D4 receptor (7907 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A2 Tclin Norepinephrine transporter (10102 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH2 Tclin Histamine H2 receptor (5428 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1D Tclin Alpha-1d adrenergic receptor (4171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2A Tclin Serotonin 2a (5-HT2a) receptor (14758 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR2C Tclin Serotonin 2c (5-HT2c) receptor (11471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR2 Tclin Vasopressin V2 receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGTR1 Tclin Type-1 angiotensin II receptor (5176 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCR Tclin Calcitonin receptor (2215 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A4 Tclin Serotonin transporter (12625 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA1B Tclin Alpha-1b adrenergic receptor (2912 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AVPR1A Tclin Vasopressin V1a receptor (5412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRD1 Tclin Delta opioid receptor (15096 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRK1 Tclin Kappa opioid receptor (16155 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC6A3 Tclin Dopamine transporter (10535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR4 Tclin Serotonin 4 (5-HT4) receptor (2068 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE3A Tclin Phosphodiesterase 3A (3309 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ESR2 Tclin Estrogen receptor beta (9272 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Agtr2 Angiotensin II type 2 (AT-2) receptor (803 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mc4r Melanocortin receptor 4 (1205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ltc4s Leukotriene C4 synthase (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Sigmar1 Sigma opioid receptor (160 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Npy1r Neuropeptide Y receptor type 1 (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cckar Cholecystokinin A receptor (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pde4d Phosphodiesterase 4D (4 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1b P-glycoprotein 1 (174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos2 Nitric oxide synthase, inducible (3573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mapk1 MAP kinase ERK2 (650 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mmp9 Matrix metalloproteinase 9 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Abcb1a P-glycoprotein 3 (492 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus (3973 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus pneumoniae (31063 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterococcus (1748 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia pneumoniae (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Campylobacter jejuni (634 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Helicobacter pylori (3113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Burkholderia cepacia (649 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Enterobacter cloacae (7976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella pneumoniae (43867 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus vulgaris (5823 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhimurium (15756 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Shigella flexneri (1836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pasteurella multocida (1166 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacteroides fragilis (1445 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptoniphilus asaccharolyticus (368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Peptostreptococcus anaerobius (347 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Micrococcus luteus (7463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus epidermidis (22802 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus haemolyticus (1695 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus hominis (482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acinetobacter baumannii (41033 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Moraxella catarrhalis (3334 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Neisseria meningitidis (411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Citrobacter freundii (1864 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Klebsiella oxytoca (929 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Proteus mirabilis (3894 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Salmonella typhi (4293 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Serratia marcescens (3237 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Haemophilus influenzae (8812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Chlamydia trachomatis (699 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Finegoldia magna (323 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Staphylococcus (1598 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Streptococcus sp. (212 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Names and Identifiers

IUPAC Name (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12,13-dihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7-methoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
INCHI InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1
InChi Key AGOYDEPGAOXOCK-KCBOHYOISA-N
Canonical SMILES CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
Isomeric SMILES CC[C@@H]1[C@@]([C@@H]([C@H](C(=O)[C@@H](C[C@@]([C@@H]([C@H]([C@@H]([C@H](C(=O)O1)C)O[C@H]2C[C@@]([C@H]([C@@H](O2)C)O)(C)OC)C)O[C@H]3[C@@H]([C@H](C[C@H](O3)C)N(C)C)O)(C)OC)C)C)O)(C)O
WGK Germany 3
RTECS KF4997000
Alternate CAS 81103-11-9,116836-41-0
PubChem CID 84029
NSC Number 758704
MeSH Entry Terms 6-O-Methylerythromycin;A 56268;A-56268;A56268;Biaxin;Clarithromycin;TE 031;TE-031;TE031
Molecular Weight 747.95

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

Specific Rotation[α]-92°C
Melt Point(°C)225°C

Safety and Hazards(GHS)

Pictogram(s) GHS07
Signal Warning
Hazard Statements

H302:Harmful if swallowed

Precautionary Statements

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P330:Rinse mouth.

P301+P317:IF SWALLOWED: Get medical help.

WGK Germany 3
RTECS KF4997000
Merck Index 2339

Related Documents

Citations of This Product

1. Rui Chen,Liu Xu,Qin Fan,Man Li,Jingjing Wang,Li Wu,Weidong Li,Jinao Duan,Zhipeng Chen.  (2017-08-29)  Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery..  Drug delivery,  24  ((1)): (1191-1203).  [PMID:28844172]
2. Xiaoyu Zhang, Peiran Meng, Wei Wang, Xiwen Li, Zuan Yang, Shaokai Du, Yue Sun.  (2023)  Simultaneous Electrochemical Determination of Erythromycin and Hemoglobin by Flexible Carbon Cloth Modified with ZnO Nanorod Arrays and Au Nanoparticles by Differential Pulse Voltammetry (DPV).  ANALYTICAL LETTERS,      [PMID:]
3. Qin Tang, Zhengcai Ma, Xiang Tang, Yan Liu, Huimin Wu, Yu Peng, Baihua Jiao, Rui Wang, Xiaoli Ye, Hang Ma, Xuegang Li.  (2023)  Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo.  JOURNAL OF ETHNOPHARMACOLOGY,    (116618).  [PMID:37164257]
4. Ruoyu Deng, Dongxu Yang, Mengli Chen, Qiang He, Qingjuan He, Yi Chen.  (2023)  The enhancing energy efficiency of sulfadiazine degradation using a DBD-contact plasma treatment process.  CHEMICAL ENGINEERING JOURNAL,  463  (142491).  [PMID:]
5. Chong Yu, Chi Li, Ying Zhang, Xiang Du, Jing-Han Wang, Zhan-You Chi, Qian Zhang.  (2023)  Effects of environment-relevant concentrations of antibiotics on seawater Chlorella sp. biofilm in artificial mariculture effluent.  Algal Research-Biomass Biofuels and Bioproducts,  70  (103008).  [PMID:]
6. Yu Wang, Yunxiang He, Qin Wang, Xiaoling Wang, Blaise L. Tardy, Joseph J. Richardson, Orlando J. Rojas, Junling Guo.  (2023)  Microporous membranes for ultrafast and energy-efficient removal of antibiotics through polyphenol-mediated nanointerfaces.  Matter,  (260-273).  [PMID:]
7. Wan-Feng Xu, Yun Wang, Hai Huang, Jia-Wei Wu, Yuan Che, Chu-Jie Ding, Quan Zhang, Wei-Ling Cao, Li-Juan Cao.  (2022)  Octreotide-based therapies effectively protect mice from acute and chronic gastritis.  EUROPEAN JOURNAL OF PHARMACOLOGY,  928  (174976).  [PMID:35487253]
8. Ling Li, Yaoyao Du, Yang Wang, Ning He, Bing Wang, Tong Zhang.  (2022)  Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites.  Journal of Inflammation Research,      [PMID:35996682]

References

1. Jerry M Zuckerman.  (2004-08-17)  Macrolides and ketolides: azithromycin, clarithromycin, telithromycin..  Infectious disease clinics of North America,  18  ((3)): (621-649).  [PMID:15308279]
2. Kathy N Williams,William R Bishai.  (2005-12-02)  Clarithromycin extended-release in community-acquired respiratory tract infections..  Expert opinion on pharmacotherapy,  ((16)): (2867-2876).  [PMID:16318437]
3. William R Bishai.  (2006-06-15)  Macrolide immunomodulatory effects and symptom resolution in acute exacerbation of chronic bronchitis and acute maxillary sinusitis: a focus on clarithromycin..  Expert review of anti-infective therapy,  ((3)): (405-416).  [PMID:16771618]
4. .  (2008-05-20)  Clarithromycin..  Tuberculosis (Edinburgh, Scotland),  88  ((2)): (92-95).  [PMID:18486039]
5. Jerry M Zuckerman,Fozia Qamar,Bartholomew R Bono.  (2009-11-17)  Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline..  Infectious disease clinics of North America,  23  ((4)): (997-1026).  [PMID:19909895]
6. M Bandettini di Poggio,Sandra Anfosso,Daniela Audenino,Alberto Primavera.  (2011-01-29)  Clarithromycin-induced neurotoxicity in adults..  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,  18  ((3)): (313-318).  [PMID:21269833]
7. Rui Lopes,Rosa Rodrigues,Isabel Domingues,Rosário Curral,António Roma-Torres.  (2012-04-25)  [Antibiomania: a case of a manic episode induced by clarithromycin]..  Acta medica portuguesa,  24  ((5)): (827-832).  [PMID:22525636]
8. Mina Gochi,Yugo Kaneko,Aya Seki,Zenya Saitou,Tsugumi Samejima,Yoshitaka Seki,Hiroshi Takeda,Akira Kinoshita,Kazuyoshi Kuwano.  (2013-02-02)  [Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report]..  Kekkaku : [Tuberculosis],  87  ((11)): (733-736).  [PMID:23367833]
9. Birgitte Johanne Schmidt,Mette Nortman Hermansen.  (2013-02-23)  [Late debut of neonatal pneumonia caused by Chlamydia trachomatis]..  Ugeskrift for laeger,  175  ((8)): (510-511).  [PMID:23428270]
10. H-M Kwak,M-Y Shin,H-H Cha,S-J Choi,J-H Lee,J-S Kim,C-R Roh,J-H Kim,S-y Oh.  (2013-03-08)  The efficacy of cefazolin plus macrolide (erythromycin or clarithromycin) versus cefazolin alone in neonatal morbidity and placental inflammation for women with preterm premature rupture of membranes..  Placenta,  34  ((4)): (346-352).  [PMID:23465535]
11. Kenji Ogawa.  (2013-03-22)  Genetic research about Mycobacterium avium complex..  Kekkaku : [Tuberculosis],  88  ((1)): (17-22).  [PMID:23513564]
12. Garvi J Pandya,Amartya Mukhopadhyay,Chua Ai Ping,Tow Keang Lim.  (2013-04-04)  Unilateral lobar pulmonary edema..  The Journal of the Association of Physicians of India,  60  (60-62).  [PMID:23547417]
13. Myrthe Joosten,Bram Flahou,Tom Meyns,Annemieke Smet,Joris Arts,Lien De Cooman,Frank Pasmans,Richard Ducatelle,Freddy Haesebrouck.  (2013-04-05)  Case report: Helicobacter suis infection in a pig veterinarian..  Helicobacter,  18  ((5)): (392-396).  [PMID:23551953]
14. Javier Molina.  (2013-04-30)  [Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]..  Gastroenterologia y hepatologia,  36  ((6)): (375-381).  [PMID:23623461]
15. .  (2013-05-11)  Bismuth + metronidazole + tetracycline. Why risk adding bismuth?.  Prescrire international,  22  ((137)): (89-92).  [PMID:23662315]
16. Stig Lyngbæk,Per Winkel,Jens P Gøtze,Jens Kastrup,Christian Gluud,Hans Jørn Kolmos,Erik Kjøller,Gorm Boje Jensen,Jørgen Fischer Hansen,Per Hildebrandt,Jørgen Hilden.  (2013-06-01)  Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide..  European journal of preventive cardiology,  21  ((10)): (1275-1284).  [PMID:23723326]
17. Marino Venerito,Tina Krieger,Thomas Ecker,Gioacchino Leandro,Peter Malfertheiner.  (2013-07-25)  Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection..  Digestion,  88  ((1)): (33-45).  [PMID:23880479]
18. Ibrahim Anwar Hassounah,Nader Abdelmonem Shehata,Gade Carolyn Kimsawatde,Amanda Gayle Hudson,Nammalwar Sriranganathan,Eugene Gregory Joseph,Roop L Mahajan.  (2014-01-01)  Studying the activity of antitubercluosis drugs inside electrospun polyvinyl alcohol, polyethylene oxide, and polycaprolacton nanofibers..  Journal of biomedical materials research. Part A,  102  ((11)): (4009-4016).  [PMID:24376010]
19. Eleonora Altman,Blair A Harrison,Vandana Chandan,Robert Slinger.  (2014-01-08)  Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori..  Canadian journal of microbiology,  60  ((1)): (35-39).  [PMID:24392924]
20. Chun-Taek Oh,Cheol Moon,Ok Kyu Park,Seung-Hae Kwon,Jichan Jang.  (2014-02-13)  Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model..  The Journal of antimicrobial chemotherapy,  69  ((6)): (1599-1607).  [PMID:24519481]
21. A B Ke,M J Zamek-Gliszczynski,J W Higgins,S D Hall.  (2014-04-22)  Itraconazole and clarithromycin as ketoconazole alternatives for clinical CYP3A inhibition studies..  Clinical pharmacology and therapeutics,  95  ((5)): (473-476).  [PMID:24747234]
22. Manthena V S Varma,Renato J Scialis,Jian Lin,Yi-An Bi,Charles J Rotter,Theunis C Goosen,Xin Yang.  (2014-05-20)  Mechanism-based pharmacokinetic modeling to evaluate transporter-enzyme interplay in drug interactions and pharmacogenetics of glyburide..  The AAPS journal,  16  ((4)): (736-748).  [PMID:24839071]
23. Wenjuan Nie,Hongfei Duan,Hairong Huang,Yu Lu,Dapeng Bi,Naihui Chu.  (2014-06-17)  Species identification of Mycobacterium abscessus subsp. abscessus and Mycobacterium abscessus subsp. bolletii using rpoB and hsp65, and susceptibility testing to eight antibiotics..  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,  25  (170-174).  [PMID:24932856]
24. Lu Lv,Tao Jiang,Shenghua Zhang,Xin Yu.  (2014-06-17)  Exposure to mutagenic disinfection byproducts leads to increase of antibiotic resistance in Pseudomonas aeruginosa..  Environmental science & technology,  48  ((14)): (8188-8195).  [PMID:24933271]
25. J William Higgins,Alice B Ke,Maciej J Zamek-Gliszczynski.  (2014-08-12)  Clinical CYP3A inhibitor alternatives to ketoconazole, clarithromycin and itraconazole, are not transported into the liver by hepatic organic anion transporting polypeptides and organic cation transporter 1..  Drug metabolism and disposition: the biological fate of chemicals,  42  ((11)): (1780-1784).  [PMID:25106415]
26. Boontida Morakul,Jiraphong Suksiriworapong,Mullika Traidej Chomnawang,Peter Langguth,Varaporn Burapacheep Junyaprasert.  (2014-09-10)  Dissolution enhancement and in vitro performance of clarithromycin nanocrystals produced by precipitation-lyophilization-homogenization method..  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,  88  ((3)): (886-896).  [PMID:25201298]
27. Javier P Gisbert,Jesús Barrio,Inés Modolell,Javier Molina-Infante,Angeles Perez Aisa,Manuel Castro-Fernández,Luis Rodrigo,Angel Cosme,Jose Luis Gisbert,Miguel Fernández-Bermejo,Santiago Marcos,Alicia C Marín,Adrián G McNicholl.  (2014-09-23)  Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy..  Digestive diseases and sciences,  60  ((2)): (458-464).  [PMID:25236423]
28. Björn Berglund,Ghazanfar Ali Khan,Richard Lindberg,Jerker Fick,Per-Eric Lindgren.  (2014-09-24)  Abundance and dynamics of antibiotic resistance genes and integrons in lake sediment microcosms..  PloS one,  ((9)): (e108151-e108151).  [PMID:25247418]
29. Beatriz E Ferro,Jakko van Ingen,Melanie Wattenberg,Dick van Soolingen,Johan W Mouton.  (2014-10-27)  Time-kill kinetics of antibiotics active against rapidly growing mycobacteria..  The Journal of antimicrobial chemotherapy,  70  ((3)): (811-817).  [PMID:25344808]
30. Nynke G L Jager,Hilde Rosing,Jan H M Schellens,Jos H Beijnen.  (2014-11-12)  Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review..  Bioanalysis,  ((18)): (2481-2514).  [PMID:25384597]
31. Byeong-Ho Jeong,Kyeongman Jeon,Hye Yun Park,Su-Young Kim,Kyung Soo Lee,Hee Jae Huh,Chang-Seok Ki,Nam Yong Lee,Sung Jae Shin,Charles L Daley,Won-Jung Koh.  (2014-11-14)  Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease..  American journal of respiratory and critical care medicine,  191  ((1)): (96-103).  [PMID:25393520]
32. Fen Jiang,Hae-Deun Kim,Han-Sung Na,Seok-Yong Lee,Doo-Won Seo,Jong-Yeol Choi,Ji-Hye Ha,Hee-Jung Shin,Young-Hoon Kim,Myeon-Woo Chung.  (2014-12-17)  The influences of CYP2D6 genotypes and drug interactions on the pharmacokinetics of venlafaxine: exploring predictive biomarkers for treatment outcomes..  Psychopharmacology,  232  ((11)): (1899-1909).  [PMID:25510856]
33. Mehra Haghi,Alessandro Saadat,Bing Zhu,Gaia Colombo,Gregory King,Paul M Young,Daniela Traini.  (2014-12-30)  Immunomodulatory effects of a low-dose clarithromycin-based macrolide solution pressurised metered dose inhaler..  Pharmaceutical research,  32  ((6)): (2144-2153).  [PMID:25537341]
34. Jie Feng,Paul G Auwaerter,Ying Zhang.  (2015-03-26)  Drug combinations against Borrelia burgdorferi persisters in vitro: eradication achieved by using daptomycin, cefoperazone and doxycycline..  PloS one,  10  ((3)): (e0117207-e0117207).  [PMID:25806811]
35. Yan-Qiang Huang,Gan-Rong Huang,Ming-Hui Wu,Hua-Ying Tang,Zan-Song Huang,Xi-Han Zhou,Wen-Qiang Yu,Jian-Wei Su,Xiao-Qiang Mo,Bing-Pu Chen,Li-Juan Zhao,Xiao-Feng Huang,Hong-Yu Wei,Lian-Deng Wei.  (2015-04-22)  Inhibitory effects of emodin, baicalin, schizandrin and berberine on hefA gene: treatment of Helicobacter pylori-induced multidrug resistance..  World journal of gastroenterology,  21  ((14)): (4225-4231).  [PMID:25892872]
36. Ayumu Ito,Hidemasa Nakaminami,Takeshi Fujii,Kenta Utsumi,Norihisa Noguchi.  (2015-05-03)  Increase in SCCmec type IV strains affects trends in antibiograms of meticillin-resistant Staphylococcus aureus at a tertiary-care hospital..  Journal of medical microbiology,  64  ((7)): (745-751).  [PMID:25934550]
37. Sasha J Rose,Lmar M Babrak,Luiz E Bermudez.  (2015-05-27)  Mycobacterium avium Possesses Extracellular DNA that Contributes to Biofilm Formation, Structural Integrity, and Tolerance to Antibiotics..  PloS one,  10  ((5)): (e0128772-e0128772).  [PMID:26010725]
38. Yoshihiko Shimokawa,Noriaki Yoda,Satoshi Kondo,Yoshiya Yamamura,Yoshiharu Takiguchi,Ken Umehara.  (2015-06-23)  Inhibitory Potential of Twenty Five Anti-tuberculosis Drugs on CYP Activities in Human Liver Microsomes..  Biological & pharmaceutical bulletin,  38  ((9)): (1425-1429).  [PMID:26094899]
39. Frantiescoli Dimer,Cristiane de Souza Carvalho-Wodarz,Jörg Haupenthal,Rolf Hartmann,Claus-Michael Lehr.  (2015-06-27)  Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections..  Pharmaceutical research,  32  ((12)): (3850-3861).  [PMID:26113237]
40. Seung Jun Lee,Chin-ok Yi,Rok Won Heo,Dae Hyun Song,Yu Ji Cho,Yi Yeong Jeong,Ki Mun Kang,Gu Seob Roh,Jong Deog Lee.  (2015-06-27)  Clarithromycin Attenuates Radiation-Induced Lung Injury in Mice..  PloS one,  10  ((6)): (e0131671-e0131671).  [PMID:26114656]
41. Shinji Ogihara,Ryoichi Saito,Teru Akikura,Akiko Iwama,Yukari Adachi,Daiki Kaji,Kyoka Kakinuma,Hiroshi Takahashi.  (2015-07-02)  Characterization of Mucoid and Non-Mucoid Streptococcus pneumoniae Isolated From Outpatients..  Annals of laboratory medicine,  35  ((4)): (410-415).  [PMID:26131412]
42. Taweesak Tongtawee,Chavaboon Dechsukhum,Wilairat Leeanansaksiri,Soraya Kaewpitoon,Natthawut Kaewpitoon,Ryan A Loyd,Likit Matrakool,Sukij Panpimanmas.  (2015-07-15)  Improved Helicobacter pylori Eradication Rate of Tailored Triple Therapy by Adding Lactobacillus delbrueckii and Streptococcus thermophilus in Northeast Region of Thailand: A Prospective Randomized Controlled Clinical Trial..  Gastroenterology research and practice,  2015  (518018-518018).  [PMID:26167176]
43. Tatsuo Koide,Yoshihisa Yamamoto,Toshiro Fukami,Noriko Katori,Haruhiro Okuda,Yukio Hiyama.  (2015-09-04)  Analysis of Distribution of Ingredients in Commercially Available Clarithromycin Tablets Using Near-Infrared Chemical Imaging with Principal Component Analysis and Partial Least Squares..  Chemical & pharmaceutical bulletin,  63  ((9)): (663-668).  [PMID:26329859]
44. Muhammad Khurram,Linda A Lawton,Christine Edwards,Marcello Iriti,Abdul Hameed,Murad A Khan,Farman A Khan,Shafiq Ur Rahman.  (2015-09-08)  Rapid Bioassay-Guided Isolation of Antibacterial Clerodane Type Diterpenoid from Dodonaea viscosa (L.) Jaeq..  International journal of molecular sciences,  16  ((9)): (20290-20307).  [PMID:26343638]
45. Min Hao,Jiangtao Lin,Jun Shu,Xiaoyan Zhang,Qiongzhen Luo,Lin Pan,Jing Guo.  (2015-09-19)  Clarithromycin might attenuate the airway inflammation of smoke-exposed asthmatic mice via affecting HDAC2..  Journal of thoracic disease,  ((7)): (1189-1197).  [PMID:26380735]
46. Chang-Er Chen,Hao Zhang,Guang-Guo Ying,Li-Jun Zhou,Kevin C Jones.  (2015-10-10)  Passive sampling: A cost-effective method for understanding antibiotic fate, behaviour and impact..  Environment international,  85  (284-291).  [PMID:26451705]
47. Peter Jacobs,Anita Conforti,Lucille Wood,Anne Kiuru,Gareth O Jones,Desmond Woolf.  (2004-12-29)  Immune agranulocytosis and clarithromycin..  Hematology (Amsterdam, Netherlands),  ((4)): (291-296).  [PMID:15621737]
48. Evangelos J Giamarellos-Bourboulis.  (2010-06-12)  Macrocycle molecules for the management of systemic infections: the clarithromycin paradigm..  Current topics in medicinal chemistry,  10  ((14)): (1470-1475).  [PMID:20536418]
49. N Radouane,F Hali,K Khadir,M Soussi,A Ouakadi,S Marouane,S Zamiati,H Benchikhi.  (2013-03-08)  [Generalized chromomycosis caused by Phialophora verrucosa]..  Annales de dermatologie et de venereologie,  140  ((3)): (197-201).  [PMID:23466152]
50. Nicholas E Gibbins,Chris Theokli,Claire Hopkins.  (2013-05-03)  Time to reconsider guidelines on clarithromycin in chronic rhinosinusitis?.  BMJ (Clinical research ed.),  346  (f2678-f2678).  [PMID:23635541]
51. Nourkhoda Sadeghifard,Teimour Seidnazari,Sobhan Ghafourian,Mohammad Soleimani,Abbas Maleki,Mostafa Akbari Qomi,Zamberi Sekawi.  (2013-05-21)  Survey in Iran of clarithromycin resistance in Helicobacter pylori isolates by PCR-RFLP..  The Southeast Asian journal of tropical medicine and public health,  44  ((1)): (89-95).  [PMID:23682442]
52. Hyun Jeong Lee,Jin Il Kim,Dae Young Cheung,Tae Ho Kim,Eun Jung Jun,Jung-Hwan Oh,Woo Chul Chung,Byung-Wook Kim,Sung Soo Kim,Soo-Heon Park,Jae Kwang Kim.  (2013-06-27)  Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance..  The Journal of infectious diseases,  208  ((7)): (1123-1130).  [PMID:23801607]
53. Janine de Zeeuw,Sridevi Duggirala,Willemien A Nienhuis,K Mohammed Abass,Wilson Tuah,Till F Omansen,Tjip S van der Werf,Ymkje Stienstra.  (2013-07-10)  Serum levels of neopterin during antimicrobial treatment for Mycobacterium ulcerans infection..  The American journal of tropical medicine and hygiene,  89  ((3)): (498-500).  [PMID:23836576]
54. Maria Paola Cecchini,Camilla Pellegrini,Maria Antonietta Bassetto,Francesco Osculati,Andrea Sbarbati,Lisa Marcolini,Manuela Pegoraro,Roberta Fontana,Lucia De Franceschi.  (2013-07-13)  Might Helicobacter pylori infection be associated with distortion on taste perception?.  Medical hypotheses,  81  ((3)): (496-499).  [PMID:23845559]
55. Dwarakanathan Ranganathan,Robert Fassett,George T John.  (2013-09-14)  Mycobacterium fortuitum peritonitis in a patient receiving continuous ambulatory peritoneal dialysis..  Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,  24  ((5)): (1003-1004).  [PMID:24029271]
56. Ming Zhang,Claudia Sala,Neeraj Dhar,Anthony Vocat,Vasan K Sambandamurthy,Sreevalli Sharma,Gwendolyn Marriner,V Balasubramanian,Stewart T Cole.  (2014-03-26)  In vitro and in vivo activities of three oxazolidinones against nonreplicating Mycobacterium tuberculosis..  Antimicrobial agents and chemotherapy,  58  ((6)): (3217-3223).  [PMID:24663022]
57. Kohei Togami,Yoshiaki Hayashi,Sumio Chono,Kazuhiro Morimoto.  (2014-05-08)  Involvement of intestinal permeability in the oral absorption of clarithromycin and telithromycin..  Biopharmaceutics & drug disposition,  35  ((6)): (321-329).  [PMID:24801141]
58. Nathalie M Vandevelde,Paul M Tulkens,Giulio G Muccioli,Françoise Van Bambeke.  (2015-02-26)  Modulation of the activity of moxifloxacin and solithromycin in an in vitro pharmacodynamic model of Streptococcus pneumoniae naive and induced biofilms..  The Journal of antimicrobial chemotherapy,  70  ((6)): (1713-1726).  [PMID:25712316]
59. Yusun Zhou,Tingting Zhou,Hua Jin,Tao Jing,Bin Song,Yikai Zhou,Surong Mei,Yong-Ill Lee.  (2015-03-17)  Rapid and selective extraction of multiple macrolide antibiotics in foodstuff samples based on magnetic molecularly imprinted polymers..  Talanta,  137  (1-10).  [PMID:25770599]
60. Hasan Kırmızıbekmez,Görkem Berk Uysal,Milena Masullo,Fatih Demirci,Yavuz Bağcı,Yüksel Kan,Sonia Piacente.  (2015-05-13)  Prenylated polyphenolic compounds from Glycyrrhiza iconica and their antimicrobial and antioxidant activities..  Fitoterapia,  103  (289-293).  [PMID:25963162]
61. Sheng Liu,Jingjing Luo,Yapu Liu,Shuangyang Tang,Chaoqun Chen,Hengling Cai,Minjun Yu,Yan Zhang.  (2015-05-27)  CD4(+) Foxp3(+) regulatory T-cell number increases in the gastric tissue of C57BL/6 mice infected with Helicobacter pylori..  APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,  123  ((7)): (571-579).  [PMID:26010562]
62. Ayşe Ufuk,Graham Somers,J Brian Houston,Aleksandra Galetin.  (2015-08-01)  In Vitro Assessment of Uptake and Lysosomal Sequestration of Respiratory Drugs in Alveolar Macrophage Cell Line NR8383..  Pharmaceutical research,  32  ((12)): (3937-3951).  [PMID:26224396]
63. Rui Chen,Liu Xu,Qin Fan,Man Li,Jingjing Wang,Li Wu,Weidong Li,Jinao Duan,Zhipeng Chen.  (2017-08-29)  Hierarchical pulmonary target nanoparticles via inhaled administration for anticancer drug delivery..  Drug delivery,  24  ((1)): (1191-1203).  [PMID:28844172]
64. Xiaoyu Zhang, Peiran Meng, Wei Wang, Xiwen Li, Zuan Yang, Shaokai Du, Yue Sun.  (2023)  Simultaneous Electrochemical Determination of Erythromycin and Hemoglobin by Flexible Carbon Cloth Modified with ZnO Nanorod Arrays and Au Nanoparticles by Differential Pulse Voltammetry (DPV).  ANALYTICAL LETTERS,      [PMID:]
65. Qin Tang, Zhengcai Ma, Xiang Tang, Yan Liu, Huimin Wu, Yu Peng, Baihua Jiao, Rui Wang, Xiaoli Ye, Hang Ma, Xuegang Li.  (2023)  Coptisine inhibits Helicobacter pylori and reduces the expression of CagA to alleviate host inflammation in vitro and in vivo.  JOURNAL OF ETHNOPHARMACOLOGY,    (116618).  [PMID:37164257]
66. Ruoyu Deng, Dongxu Yang, Mengli Chen, Qiang He, Qingjuan He, Yi Chen.  (2023)  The enhancing energy efficiency of sulfadiazine degradation using a DBD-contact plasma treatment process.  CHEMICAL ENGINEERING JOURNAL,  463  (142491).  [PMID:]
67. Chong Yu, Chi Li, Ying Zhang, Xiang Du, Jing-Han Wang, Zhan-You Chi, Qian Zhang.  (2023)  Effects of environment-relevant concentrations of antibiotics on seawater Chlorella sp. biofilm in artificial mariculture effluent.  Algal Research-Biomass Biofuels and Bioproducts,  70  (103008).  [PMID:]
68. Yu Wang, Yunxiang He, Qin Wang, Xiaoling Wang, Blaise L. Tardy, Joseph J. Richardson, Orlando J. Rojas, Junling Guo.  (2023)  Microporous membranes for ultrafast and energy-efficient removal of antibiotics through polyphenol-mediated nanointerfaces.  Matter,  (260-273).  [PMID:]
69. Wan-Feng Xu, Yun Wang, Hai Huang, Jia-Wei Wu, Yuan Che, Chu-Jie Ding, Quan Zhang, Wei-Ling Cao, Li-Juan Cao.  (2022)  Octreotide-based therapies effectively protect mice from acute and chronic gastritis.  EUROPEAN JOURNAL OF PHARMACOLOGY,  928  (174976).  [PMID:35487253]
70. Ling Li, Yaoyao Du, Yang Wang, Ning He, Bing Wang, Tong Zhang.  (2022)  Atractylone Alleviates Ethanol-Induced Gastric Ulcer in Rat with Altered Gut Microbiota and Metabolites.  Journal of Inflammation Research,      [PMID:35996682]

Solution Calculators